Format

Send to

Choose Destination
Nat Rev Rheumatol. 2012 Apr 10;8(5):269-79. doi: 10.1038/nrrheum.2012.37.

New advances in juvenile spondyloarthritis.

Author information

1
Division of Rheumatology, The Hospital for Sick Children, 555 University Avenue, University of Toronto, Toronto, ON, M5G 1X8, Canada. shirley.tse@sickkids.ca

Abstract

Juvenile spondyloarthritis (SpA) is a distinct disease to adult SpA, and usually manifests as peripheral arthritis and enthesitis. Importantly, many patients with juvenile SpA continue to be at risk of developing ankylosing spondylitis during their disease course. In this Review, the classification and diagnostic criteria, clinical manifestations and treatment guidelines for juvenile SpA will be discussed. Advances in the diagnosis of and management strategies for juvenile SpA will lead to earlier recognition, appropriate treatment and improved rates of inactive disease, which should lead to improved patient outcomes and quality of life.

PMID:
22487801
DOI:
10.1038/nrrheum.2012.37
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center